Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognition in Schizophrenia”

386 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 386 results

Very early researchStudy completedNCT02566356
What this trial is testing

Adult Study Oxytocin - fMRI

Who this might be right for
SchizophreniaOxytocinSocial Cognition+1 more
University of California, San Francisco 59
Early research (Phase 1)Study completedNCT05342727
What this trial is testing

Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia

Who this might be right for
SchizophreniaCognitive Dysfunction
The National Brain Mapping Laboratory (NBML) 50
Testing effectiveness (Phase 2)Study completedNCT01488929
What this trial is testing

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Who this might be right for
SchizophreniaNegative SymptomsCognitive Dysfunction
Targacept Inc. 603
Not applicableStudy completedNCT01773239
What this trial is testing

Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia

Who this might be right for
Schizophrenia
Posit Science Corporation 16
Not applicableEnded earlyNCT00169949
What this trial is testing

Aripiprazole Treatment of the Prodrome

Who this might be right for
Prodromal SchizophreniaProdromal Psychosis
Northwell Health 30
Early research (Phase 1)Study completedNCT01346163
What this trial is testing

Add On Treatment for Cognitive Deficits in Schizophrenia

Who this might be right for
Schizophrenia
University of Pennsylvania 16
Post-approval studies (Phase 4)Study completedNCT00320736
What this trial is testing

Galantamine for Cognition in People With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
North Suffolk Mental Health Association 20
Early research (Phase 1)Study completedNCT01885338
What this trial is testing

N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia

Who this might be right for
Schizophrenia
VA Greater Los Angeles Healthcare System 26
Post-approval studies (Phase 4)Study completedNCT00611806
What this trial is testing

Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 140
Post-approval studies (Phase 4)Study completedNCT00492349
What this trial is testing

Varenicline Adjunctive Treatment in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
University of Maryland, Baltimore 91
Not applicableLooking for participantsNCT06978452
What this trial is testing

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories

Who this might be right for
Depression - Major Depressive DisorderBipolarPsychosis+4 more
Douglas Mental Health University Institute 560
Post-approval studies (Phase 4)UnknownNCT01012830
What this trial is testing

Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia

Who this might be right for
SchizophreniaDementia
VA Nebraska Western Iowa Health Care System 15
Not applicableStudy completedNCT04557124
What this trial is testing

USS Training to Improve Social Function in People With Psychosis

Who this might be right for
Psychosis
VA Office of Research and Development 113
Large-scale testing (Phase 3)Ended earlyNCT00148616
What this trial is testing

Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
M. Schaefer, MD 13
Not applicableStudy completedNCT04681807
What this trial is testing

Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

Who this might be right for
Schizophrenia
The Royal Ottawa Mental Health Centre 82
Not applicableLooking for participantsNCT04143126
What this trial is testing

Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)

Who this might be right for
Schizophrenia
University of Pittsburgh 90
Post-approval studies (Phase 4)Study completedNCT00492336
What this trial is testing

Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 84
Testing effectiveness (Phase 2)Study completedNCT00505765
What this trial is testing

Study of NAP (AL-108) in Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 63
Not applicableLooking for participantsNCT06482918
What this trial is testing

Cognitive Remediation in Schizophrenia: Efficacy and Role of Neuroplasticity in "Top-down" and "Bottom-up" Mechanisms

Who this might be right for
Schizophrenia
University of Chile 160
Post-approval studies (Phase 4)Study completedNCT00373672
What this trial is testing

Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 58
Load More Results